For instance, ketoacidosis, a life-threatening complication of diabetes, has been reported as a potential side effect of both SGLT2 inhibitors [111] and ketogenic diets [112], though the underlying mechanisms are not fully understood. This evidence concerns the gene SLC5A2 and diabetes mellitus.